Osteoporosis is the index disease for calcium deficiency, just as rickets/osteomalacia is the index disease for vitamin D deficiency, but there is considerable overlap between them. The common explanation for this overlap is that hypovitaminosis D causes malabsorption of calcium which then causes secondary hyperparathyroidism and is effectively the same thing as calcium deficiency. This paradigm is incorrect. Hypovitaminosis D causes secondary hyperparathyroidism at serum calcidiol levels lower than 60 nmol/L long before it causes malabsorption of calcium because serum calcitriol (which controls calcium absorption) is maintained until serum calcidiol falls below 20 nmol/L. This secondary hyperparathyroidism, probably due to loss of a “calcaemic” action of vitamin D on bone first described in 1957, destroys bone and explains why vitamin D insufficiency is a risk factor for osteoporosis. Vitamin D thus plays a central role in the maintenance of the serum (ionised) calcium, which is more important to the organism than the preservation of the skeleton. Bone is sacrificed when absorbed dietary calcium does not match excretion through the skin, kidneys and bowel which is why calcium deficiency causes osteoporosis in experimental animals and, by implication, in？humans.
References
[1]
Heaney, R.P. Long-latency deficiency disease: insights from calcium and vitamin D. Am. J. Clin. Nutr.？2003, 7, 912–919.
Pommer, G. Untersuchungen uber Osteomalacie und Rachitis; Vogel: Leipzig, Germany, 1885.
[4]
Miwa, S.; Stoeltzner, W. über die bei jungen Hunden durch kalk？rme Fütterung enstehende Knochenerkrankung. Beitr. Pathol. Anat.？1898, 24, 578.
[5]
Mellanby, E. An experimental investigation on rickets. Lancet？1919, 1, 407–412.
[6]
Telfer, S.V. Studies in calcium and phosphorus metabolism. Q. J. Med.？1926, 20, 1–6.
[7]
Albright, F.; Reifenstein, E.C. The Parathyroid Glands and Metabolic Bone Disease; Williams and Wilkins: Baltimore, MD, USA, 1948.
[8]
Carlsson, A.; Lindquist, B. Comparison of intestinal and skeletal effects of vitamin D in relation to dosage. Acta Physiol. Scand.？1955, 35, 53–55.
[9]
Need, A.G.; O’Loughlin, P.D.; Morris, H.A.; Coates, P.S.; Horowitz, M.; Nordin, B.E.C. Vitamin D metabolites and calcium absorption in severe vitamin D deficiency. J. Bone Miner. Res.？2008, 23, 1859–1863.
[10]
Aaron, J.E.; Gallagher, J.C.; Anderson, J.; Stasiak, L.; Longton, E.B.; Nordin, B.E.C. Frequency of osteomalacia and osteoporosis in fractures of the proximal femur. Lancet？1974, 1, 229–233.
[11]
Baker, M.R.; McDonnell, H.; Peacock, M.; Nordin, B.E.C. Plasma 25-hydroxy vitamin D concentrations in patients with fractures of the femoral neck. BMJ？1979, 1, 589.
[12]
Morris, H.A.; Morrison, G.W.; Burr, M.; Thomas, D.W.; Nordin, B.E.C. Vitamin D and femoral neck fractures in elderly South Australian women. Med. J. Aust.？1984, 140, 519–521.
Lian, J.B.; Carnes, D.L.; Glimcher, M.J. Bone and serum concentrations of osteocalcin as a function of 1,25-dihydroxyvitamin D3 circulating levels in bone disorders in rats. Endocrinology？1987, 120, 2123–2130.
[15]
Avioli, L.V.; McDonald, J.E.; Singer, R.A.; Henneman, P.H. A new oral istotopic test of calcium absorption. J. Clin. Invest.？1965, 44, 128–139.
[16]
Marshall, D.H.; Nordin, B.E.C. Kinetic analysis of plasma radioactivity after oral ingestion of radiocalcium. Nature？1969, 222, 797.
[17]
Nordin, B.E.C.; Horsman, A.; Aaron, J. Diagnostic procedures. In Calcium, Phosphate and Magnesium Metabolism; Nordin, B.E.C., Ed.; Churchill Livingstone: Edinburgh, Scotland, UK, 1976; pp. 1–35.
[18]
Marshall, D.H.; Nordin, B.E.C. A comparison of radioactive calcium absorption tests with net calcium absorption. Clin. Sci.？1981, 61, 477–481.
[19]
Bullamore, J.R.; Gallagher, J.C.; Wilkinson, R.; Nordin, B.E.C. Effect of age on calcium absorption. Lancet？1970, 2, 535–537.
[20]
Nordin, B.E.C.; Wilkinson, R.; Marshall, D.H.; Gallagher, J.C.; Williams, A.; Peacock, M. Calcium absorption in the elderly. Calcif. Tissue Int.？1976, 21, 442–451.
[21]
Peacock, M.; Nordin, B.E.C.; Gallagher, J.C.; Varnavides, C. Action of 1α-hydroxy vitamin D3 in man. In Vitamin D and Problems to Uremic Bone Disease; Norman, A.W., Schaefer, K., Grigoleit, H.-G., Herrath, D.V., Eds.; deGruyter: Berlin, Germany, 1975; pp. 611–617.
[22]
Nordin, B.E.C.; Peacock, M.; Crilly, R.G.; Marshall, D.H. Calcium absorption and plasma 1,25(OH)2D levels in postmenopausal osteoporosis. In Vitamin D: Basic Research and Its Clinical Application; Norman, A.W., Schaefer, K., Grigoleit, H.-G., Herrath, D.V., Eds.; deGruyter: Berlin, Germany, 1979; pp. 96–106.
[23]
Nordin, B.E.C.; Peacock, M.; Crilly, R.G.; Taylor, G.; Marshall, D.H. Plasma 25hydroxy and 1,25dihydroxyvitamin D levels and calcium absorption in postmenopausal women. In Molecular Endocrinology; MacIntyre, I., Szelke, M., Eds.; Elsevier: Amsterdam, The Netherlands, 1979; pp. 363–373.
[24]
Francis, R.M.; Peacock, M.; Barkworth, S.A.; Marshall, D.H. A comparison of the effect of sorbitol and glucose on calcium absorption in postmenopausal women. Am. J. Clin. Nutr.？1986, 43, 72–76.
[25]
Nordin, B.E.C.; Morris, H.A.; Wishart, J.M.; Scopacasa, F.; Horowitz, M.; Need, A.G.; Clifton, P.M. Modification and validation of a single-isotope radiocalcium absorption test. J. Nucl. Med.？1998, 39, 108–113.
[26]
Wishart, J.M.; Horowitz, M.; Need, A.G.; Scopacasa, F.; Morris, H.A.; Clifton, P.M.; Nordin, B.E.C. Relations between calcium intake, calcitriol, polymorphisms of the vitamin D receptor gene, and calcium absorption in premenopausal women. Am. J. Clin. Nutr.？1997, 65, 798–802. 9062532
[27]
Need, A.G.; Horowitz, M.; Philcox, J.C.; Nordin, B.E.C. 1,25-dihydroxycalciferol and calcium therapy in osteoporosis with calcium malabsorption. Miner. Electrolyte Metab.？1985, 11, 35–40.
[28]
Nordin, B.E.C.; Morris, H.A.; Horowitz, M.; Coates, P.S; O’Loughlin, P.D.; Need, A.G. Calcium malabsorption does not cause secondary hyperparathyroidism. Calcif. Tissue Int.？2009, 85, 31–36.
[29]
Nordin, B.E.C.; Need, A.G.; Morris, H.A.; O’Loughlin, P.D.; Horowitz, M. Effect of age on calcium absorption in postmenopausal women. Am. J. Clin. Nutr.？2004, 80, 998–1002.
[30]
Wood, R.J.; Fleet, J.C.; Cashman, K.; Bruns, M.E.; DeLuca, H.F. Intestinal calcium absorption in the aged rat: evidence of intestinal resistance to 1,25(OH)2 vitamin D. Endocrinology？1998, 139, 3843–3848.
[31]
Nordin, B.E.C.; Wishart, J.M.; Clifton, P.M.; McArthur, R.; Scopacasa, F.; Need, A.G.; Morris, H.A.; O’Loughlin, P.D.; Horowitz, M. A longitudinal study of bone-related biochemical changes at the menopause. Clin. Endocrinol.？2004, 61, 123–130.
[32]
O’Loughlin, P.D.; Morris, H.A. Oestrogen deficiency impairs intestinal calcium absorption in the rat. J. Physiol.？1998, 511, 313–322.
[33]
Need, A.G.; Morris, H.A.; Horowitz, M.; Nordin, B.E.C. The response to calcitriol therapy in postmenopausal osteoporotic women is a function of initial calcium absorptive status. Calcif. Tissue Int.？1997, 61, 6–9.
[34]
Ensrud, K.E.; Duong, T.; Cauley, J.A.; Heaney, R.P.; Wolf, R.L.; Harris, E.; Cummings, S.R. Low fractional calcium absorption increases the risk for hip fracture in women with low calcium intake. Ann. Intern. Med.？2000, 132, 345–353.
[35]
Nordin, B.E.C.; O’Loughlin, P.D.; Need, A.G.; Horowitz, M.; Morris, H.A. Radiocalcium absorption is reduced in postmenopausal women with vertebral and most types of peripheral fractures. Osteoporos. Int.？2004, 15, 27–31.
[36]
Need, A.G.; Horowitz, M.; Philcox, J.C.; Nordin, B.E.C. 1,25-dihydroxycalciferol and calcium therapy in osteoporosis with calcium malabsorption. Miner. Electrolyte Metab.？1985, 1, 35–40.
[37]
Francis, R.M.; Peacock, M.; Taylor, G.A.; Storer, J.H.; Nordin, B.E.C. Calcium malabsorption in elderly women with vertebral fractures: evidence for resistance to the action of vitamin D metabolites on the bowel. Clin. Sci.？1984, 66, 103–110.
[38]
Heaney, R.P.; Dowell, M.S.; Hale, C.A.; Bendich, A. Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. J. Am. Coll. Nutr.？2003, 22, 142–146.
[39]
Stamp, T.C.B.; Haddad, J.G.; Twigg, C.A. Comparison of oral 25-hydroxycholecalciferol, vitamin D, and ultraviolet light as determinants of circulating 25-hydroxyvitamin D. Lancet？1977, 1, 1341–1343. 69059
[40]
Jesudason, D.; Need, A.G.; Horowitz, M.; O’Loughlin, P.D.; Morris, H.A.; Nordin, B.E.C. Relationship between serum 25-hydroxyvitamin D and bone resorption markers in vitamin D insufficiency. Bone？2002, 31, 626–630.
[41]
Tang, B.M.P.; Eslick, G.D.; Nowson, C.; Smith, C.; Bensoussan, A. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet？2007, 370, 657–666.
[42]
Boonen, S.; Lips, P.; Bouillon, R.; Bischoff-Ferrari, H.A.; Vanderschueren, D.; Haentjens, P. Need for additional calcium to reduce the risk of hip fracture with vitamin D supplementation: evidence from a comparative metaanalysis of randomized controlled trials. J. Clin. Endocrinol. Metab.？2007, 92, 1415–1423.
[43]
Bischoff-Ferrari, H.A.; Willett, W.C.; Wong, J.B.; Stuck, A.E.; Staehelin, H.B.; Orav, E.J.; Thoma, A.; Kiel, D.P.; Henschkowski, J. Prevention of nonvertebral fractures with oral vitamin D and dose dependency. Arch. Intern. Med.？2009, 169, 551–561.
[44]
FAO/WHO. Human Vitamin and Mineral Requirements; Report of a joint FAO/WHO expert consultation, Bangkok, Thailand; Food and Agriculture Organization of the United Nations/World Health Organization: Rome, Italy, 2002.
[45]
Nordin, B.E.C. Reflections on osteoporosis. In Osteoporosis, 3rd; Marcus, R., Feldman, D., Nelson, D.A., Rosen, C.J., Eds.; Elsevier-Academic Press: San Diego, CA, USA, 2008; Volume 1, p. 47.
Nordin, B.E.C. The effect of calcium supplementation on bone loss in 32 controlled trials in postmenopausal women. Osteoporos. Int.？2009, 20, 2125–2143.
[48]
Khosla, S.; Melton, L.J. Osteopenia. N. Engl. J. Med.？2007, 356, 2293–2330.
